GRP78 in Glioma Progression and Therapy: Implications for Targeted Approaches
Glioma is the most common primary malignant brain tumor, accounting for the majority of brain cancer-related deaths. Considering the limited efficacy of conventional therapies, novel molecular targeted therapies have been developed to improve outcomes and minimize toxicity. Glucose-regulated protein...
| Published in: | Biomedicines |
|---|---|
| Main Authors: | , , , , , , |
| Format: | Article |
| Language: | English |
| Published: |
MDPI AG
2025-02-01
|
| Subjects: | |
| Online Access: | https://www.mdpi.com/2227-9059/13/2/382 |
